Inventor · disambiguated record
Shubha Chungi
Also filed as: CHUNGI SHUBHA
5 granted patents·9 pending applications·331 citations·filing 1999–2010
84Inventor score
Files withCOLLEGIUM PHARMACEUTICAL INC5CHUNGI SHUBHA2LONGWOOD PHARMACEUTICAL RES IN1PHARMAQUEST LTD1TEVA PHARMA1
Top patents by PatentIndex Score
14 records- 0194US6340476B1Pharmaceutical dosage form for pulsatile delivery of methylphenidatePHARMAQUEST LTD·Filed 2000·Granted Jan 22, 2002·108 cites·56 claims
- 0294US6306436B1Stabilized, acid-free formulation for sustained release of bupropion hydrochlorideTEVA PHARMA·Filed 2000·Granted Oct 23, 2001·136 cites·36 claims
- 0389US6669955B2Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirinLONGWOOD PHARMACEUTICAL RES IN·Filed 2001·Granted Dec 30, 2003·78 cites·59 claims
- 0485US7704527B2Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2008·Granted Apr 27, 2010·8 cites·17 claims
- 0568US8021687B2Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2010·Granted Sep 20, 2011·1 cites·30 claims
- 0661US2004122104A1Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2003·Application pending·0 cites
- 0753US2004132826A1Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2003·Application pending·0 cites
- 0852US2003194439A1Pharmaceutical dosage form for pulsatile delivery of methylphenidateFiled 2003·Application pending·0 cites
- 0950US2006275367A1Extended release formulationsCHUNGI SHUBHA·Filed 2006·Application pending·0 cites
- 1050US2006024366A1Modified release compositions of milnacipranCOLLEGIUM PHARMACEUTICAL INC·Filed 2005·Application pending·0 cites
- 1147US2004185170A1Method for coating drug-containing particles and formulations and dosage units formed therefromFiled 2003·Application pending·0 cites
- 1246US2004043064A1Dosage forms having reduced moisture transmissionFiled 2002·Application pending·0 cites
- 1338US2006240101A1Orally disintegrating pharmaceutical tablet formulations of olanzapineCHUNGI SHUBHA·Filed 2006·Application pending·0 cites
- 1428US2002102309A1Controlled release formulation for administration of an anti-inflammatory naphthalene derivativeFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →